GEMI vs HIVE

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 25, 2026

GEMI

40.3
AI Score
VS
GEMI Wins

HIVE

33.9
AI Score

Investment Advisor Scores

GEMI

40score
Recommendation
HOLD

HIVE

34score
Recommendation
EXTENDED

AI Analyst Insights

Detailed Metrics Comparison

Metric GEMI HIVE Winner
Forward P/E 0 62.8931 Tie
PEG Ratio 0 0 Tie
Revenue Growth 36.6% 73.5% HIVE
Earnings Growth 0.0% -99.9% GEMI
Tradestie Score 40.3/100 33.9/100 GEMI
Profit Margin -250.1% -98.5% HIVE
Beta 1.00 1.00 Tie
AI Recommendation HOLD EXTENDED Tie

Relative Price Performance (Last 90 Days)

GEMI 1M: +8.9% · 3M: +5.9% HIVE 1M: +9.4% · 3M: -12.0%

Current Technical Phase

GEMI

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 46

RSI (14): 45.9 · Price: $4.67

HIVE

Distribution
Trim / tighten stop

Price near a flattening SMA50 (slope -2.6%) with fading momentum, RSI 46

RSI (14): 46.5 · Price: $2.98

Fundamentals Snapshot

Metric GEMI HIVE
Market Cap — —
Forward P/E -2.3 -5.8
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.4% 0.7%
Gross Margin -0.3% 0.4%
Operating Margin -1.7% -0.6%
EPS -14.71 -1.39
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, GEMI is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.